You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 5, May 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Viral Infections
 •Dermatology
 •Dermatologic Disorders
 •Herpes
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

VIGNETTES
Adults With Atopic Dermatitis and Herpes Simplex and Topical Therapy With Tacrolimus: What Kind of Prevention?

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Eczema herpeticatum is well known as a complication associated with atopic dermatitis. We previously reported 2 cases that developed in adult patients during treatment of their atopic dermatitis with tacrolimus ointment.1 In a 1-year open study in adult patients with atopic dermatitis who were treated with tacrolimus ointment, eczema herpeticatum was observed at low frequencies (1.8%), but the data were insufficient to establish a causal relationship.2 Nevertheless, prevention is important, as the complication is potentially serious and may compromise a promising treatment alternative in a patient with atopic dermatitis.

Preventive recommendations against infectious complications due to herpes simplex virus during treatment with tacrolimus ointment have been limited to the common sense advice to interrupt the treatment until bacterial or viral infections have cleared.3 This strategy primarily concerns patients with recognized symptomatic infection, ie, individuals who know about the symptoms and aspect of their recrudescent herpes simplex lesions and therefore may . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.